Clinical Trial Update: ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of ME-344 in combination with bevacizumab for previously treated metastatic colorectal cancer has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• ME-344

Snippet

Sponsor: MEI Pharma, Inc. | Conditions: Colorectal Cancer | Phase 1 | Status: TERMINATED | Results posted: 2024-11-21